1-13c acetate
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2015 (NCT02876796)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 13-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- 1-13c acetate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04430660 | N/A | Aug 31, 2020 | Pennington Biomedical Research Center |
| NCT04207619 | N/A | Feb 19, 2020 | Pennington Biomedical Research Center |
| NCT02876796 | Phase 1 | Aug 1, 2015 | Gilead Sciences, Nimbus Apollo |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pennington Biomedical Research Center | Academic/Hospital | 2 | 2 | 1 | 2020 |
| Gilead Sciences | For profit | 1 | 1 | 1 | 2015 |
| Nimbus Apollo | For profit | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1